Repligen Corporation

NASDAQ: RGEN · Real-Time Price · USD
127.54
-3.76 (-2.86%)
At close: Jun 13, 2025, 3:59 PM
125.00
-1.99%
After-hours: Jun 13, 2025, 05:17 PM EDT

Repligen Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Chromatography Products Revenue 122.81M 126.63M 131.68M 91.04M 73.55M 64.64M 45.33M 36.31M 29.52M
Chromatography Products Revenue Growth -3.02% -3.84% +44.64% +23.77% +13.79% +42.60% +24.83% +23.00% n/a
Filtration Products Revenue 372.96M 347.78M 495.93M 403.5M 174.9M 119.53M 90.59M 49.05M 19.77M
Filtration Products Revenue Growth +7.24% -29.87% +22.91% +130.71% +46.31% +31.96% +84.68% +148.05% n/a
Other products Revenue 4.68M 3.69M 5.74M 4.05M 3.61M 4.4M 3.6M 1.76M 431K
Other products Revenue Growth +26.87% -35.76% +41.72% +12.18% -17.91% +22.06% +104.66% +308.58% n/a
Process Analytics Products Revenue 59.3M 56.82M 53.51M 48.02M 33.35M 16.41M n/a n/a n/a
Process Analytics Products Revenue Growth +4.37% +6.18% +11.44% +44.00% +103.27% n/a n/a n/a n/a
Product Revenue 634.18M 638.38M 801.18M 670.32M 366.14M 270.1M n/a n/a n/a
Product Revenue Growth -0.66% -20.32% +19.52% +83.08% +35.56% n/a n/a n/a n/a
Proteins Products Revenue 74.42M 103.46M 114.32M 123.71M 80.73M 65.12M n/a n/a n/a
Proteins Products Revenue Growth -28.07% -9.50% -7.59% +53.23% +23.97% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 71.25M 56.63M 73.94M 64.7M 60.99M 57.51M 55.47M 48.97M 56.17M 53.24M 53.64M 54.65M 54.3M 52.06M 48.37M 44.34M 39.09M 36.34M 29.05M 26.73M 27.5M 28.29M 24.63M 23.7M 19M 17.98M 15.86M 16.59M 15.9M 16.14M 15M 11.19M 9.18M 8.57M 7.13M 8.14M 7.02M 6.47M 5.96M 6.24M 6.02M
Selling, General, and Administrative Revenue Growth +25.83% -23.41% +14.29% +6.09% +6.04% +3.69% +13.27% -12.83% +5.51% -0.76% -1.84% +0.64% +4.31% +7.62% +9.09% +13.42% +7.57% +25.10% +8.70% -2.81% -2.78% +14.85% +3.92% +24.74% +5.69% +13.35% -4.41% +4.35% -1.53% +7.65% +34.09% +21.81% +7.18% +20.20% -12.44% +15.99% +8.42% +8.63% -4.54% +3.61% n/a
Research and Development Revenue 12.92M 11.68M 9.71M 10.57M 11.24M 10.29M 10.58M 9.71M 12.15M 11.11M 10.23M 10.44M 12.15M 9.12M 9.15M 8.39M 7.61M 6.72M 4.42M 4.34M 4.7M 5.17M 5.43M 5.23M 3.62M 3.1M 3.6M 5.78M 3.29M 3.07M 2M 1.86M 1.74M 2.04M 1.89M 1.89M 1.54M 1.43M 1.49M 1.25M 1.57M
Research and Development Revenue Growth +10.68% +20.26% -8.18% -5.90% +9.27% -2.76% +8.97% -20.14% +9.37% +8.65% -2.03% -14.11% +33.29% -0.38% +9.12% +10.21% +13.24% +52.01% +1.98% -7.78% -9.09% -4.70% +3.75% +44.50% +16.81% -13.94% -37.70% +75.79% +7.17% +53.32% +7.58% +6.77% -14.61% +8.17% -0.21% +22.81% +7.55% -3.96% +19.05% -20.16% n/a